Advances in Clinical and Experimental Medicine
2018, vol. 27, nr 12, December, p. 1691–1695
doi: 10.17219/acem/75902
Publication type: original article
Language: English
Download citation:
Carotid artery stenting versus endarterectomy for the treatment of both symptomatic and asymptomatic patients with carotid artery stenosis: 2 years’ experience in a high-volume center
1 Division of Surgical Procedures, Department of Clinical Nursing, Faculty of Health Sciences, Wroclaw Medical University, Poland
2 Department of Surgery, 4th Military Teaching Hospital, Wrocław, Poland
3 Division of Oncology and Palliative Care, Faculty of Health Sciences, Wroclaw Medical University, Poland
4 Department of Otolaryngology, Head and Neck Surgery, Faculty of Postgraduate Medical Training, Wroclaw Medical University, Poland
Abstract
Background. Carotid endarterectomy (CEA) and carotid artery stenting (CAS) are the 2 current standard treatments for carotid artery stenosis. There is still no well-defined consensus with regard to their superiority. However, the minimally invasive nature of endovascular treatment makes CAS increasingly popular among vascular surgeons.
Objectives. The aim of the study is to compare the safety and efficacy of CEA and CAS in patients with symptomatic and asymptomatic carotid artery stenosis.
Material and Methods. A single-center, retrospective analysis of patients who were treated for carotid artery stenosis using CAS or CEA between January 2014 and December 2015 was carried out. There were 471 patients (266 CEA and 205 CAS) who were eligible for inclusion. The vast majority of the patients had significant (>70%) stenosis of the internal carotid artery (92.1% of CEA and 87.8% of CAS). The occlusion of the contralateral carotid artery was observed in 9.8% of all cases (2.6% of CEA vs 17.7% of CAS).
Results. The occurrence of complications, such as stroke, myocardial infarction (MI) and death, did not vary statistically between the groups. There were 9 events of stroke in the CEA group (3.4%) and 8 in the CAS group (3.9%), 3 of which were fatal. There were no significant differences between the 2 groups (χ2 = 0.76; p > 0.05). There was no higher risk of mortality in any group (Fisher’s exact test; p = 0.08). Symptomatic patients had a higher incidence of stroke than asymptomatic patients across both groups (χ2 = 6.36; p < 0.05; hazard ratio 3.03 (1.26–7.33)).
Conclusion. Carotid endarterectomy is equally effective as CAS in stroke prevention, but is associated with a higher incidence of cranial nerve palsy, access site hematoma and other non-stroke complications. Symptomatic patients had a higher incidence of stroke, regardless of the treatment method.
Key words
carotid artery stenting, carotid endarterectomy, carotid artery stenosis
References (13)
- Mas JL, Trinquart L, Leys D, et al. Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: Results up to 4 years from a randomised, multicentre trial. Lancet Neurol. 2008;7(10):885–892.
- Brott TG, Hobson RW, Howard G, et al. Stenting vs endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363(1):11–23.
- Mantese VA, Timaran CH, Chiu D, Begg RJ, Brott TG. The Carotid Revascularization Endarterectomy vs Stenting Trial (CREST): Stenting versus carotid endarterectomy for carotid disease. Stroke. 2010;41(Suppl 10):31–34.
- Voeks JH, Howard G, Roubin GS, et al. Age and outcomes after carotid stenting and endarterectomy: The carotid revascularization endarterectomy vs stenting trial. Stroke. 2011;42(12):3484–3490.
- Timaran CH, Mantese VA, Malas M, et al. Differential outcomes of carotid stenting and endarterectomy performed exclusively by vascular surgeons in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). J Vasc Surg. 2013;57(2):303–308.
- Bonati LH, Dobson J, Featherstone RL, et al. Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: The International Carotid Stenting Study (ICSS) randomised trial. Lancet. 2015;385(9967):529–538.
- Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): A randomised trial. Lancet. 2001;357(9270):1729–1737.
- Schofer J, Musiałek P, Bijuklic K, et al. A prospective, multicenter study of a novel mesh-covered carotid stent: The CGuard CARENET Trial (Carotid Embolic Protection Using MicroNet). JACC Cardiovasc Interv. 2015;8(9):1229–1234.
- Bonati LH, Jongen LM, Haller S, et al. New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: A substudy of the International Carotid Stenting Study (ICSS). Lancet Neurol. 2010;9(4):353–362.
- Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160–2236.
- Ederle J, Dobson J, Featherstone RL, et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): An interim analysis of a randomised controlled trial. Lancet. 2010;375(9719):985–997.
- Chaturvedi S, Bruno A, Feasby T, et al. Carotid endarterectomy – an evidence-based review: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2005;65(6):794–801.
- Bradac O, Mohapl M, Kramar F, et al. Carotid endarterectomy and carotid artery stenting: Changing paradigm during ten years in a high-volume centre. Acta Neurochir (Wien). 2014;156(9):1705–1712.


